tiprankstipranks
Trending News
More News >
Marker Therapeutics (MRKR)
NASDAQ:MRKR
US Market

Marker Therapeutics (MRKR) Income Statement

Compare
586 Followers

Marker Therapeutics Income Statement

Last quarter (Q3 2025), Marker Therapeutics's total revenue was $1.23M, a decrease of -35.98% from the same quarter last year. In Q3, Marker Therapeutics's net income was $-2.00M. See Marker Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 6.59M$ 3.31M$ 3.51M$ 1.24M$ 466.79K
Gross Profit
$ -6.88M$ -7.11M$ -8.45M$ -1.92M$ -18.41M
Operating Expenses
$ 4.24M$ 7.48M$ 11.34M$ 37.56M$ 10.47M
Depreciation and Amortization
$ 2.00$ 2.79M$ 2.79M$ 3.16M$ 1.08M
EBITDA
$ -11.12M$ -11.79M$ -17.00M$ -38.72M$ -27.63M
Operating Income
$ -11.12M$ -14.58M$ -19.79M$ -39.48M$ -28.89M
Other Income/Expenses
$ 437.01K$ 539.16K$ 15.09K$ -2.40M$ 179.74K
Pretax Income
$ -10.68M$ -14.04M$ -19.78M$ -41.88M$ -28.71M
Net Income
$ -10.73M$ -8.24M$ -29.93M$ -41.88M$ -28.71M
Per Share Metrics
Basic EPS
$ -1.19$ -1.93$ -3.58$ -5.47$ -6.10
Diluted EPS
$ -1.19$ -1.93$ -3.58$ -5.47$ -6.10
Weighted Average Shares Outstanding
8.98M 8.81M 8.35M 7.65M 4.70M
Weighted Average Shares Outstanding (Diluted)
8.98M 8.81M 8.35M 7.65M 4.70M
Currency in USD

Marker Therapeutics Earnings and Revenue History